Cell Culture Media Storage Containers Market Analysis
Based on product, the global market is classified into storage bag, Storage bottle, storage bin & drum, and other products. In the year 2022, storage bag segment dominated the market with a substantial share of 41.1%. These bags come in various sizes and configurations, allowing flexibility and scalability in bioprocessing.
- Storage bags can be chosen based on the specific volume requirements, providing a scalable solution for both small-scale and large-scale production. Additionally, giving advantages such as minimizing the risk of cross-contamination between different batches of cell cultures, and cost effectiveness.
- Moreover, storage bags are designed for aseptic use, and they often come pre-sterilized. This ensures that the cell culture media remains uncontaminated during storage. Aseptic handling is critical in maintaining the quality of cell cultures, and storage bags are engineered to meet these stringent requirements. Thus, the aforementioned factors are projected to augment the segment trends.
Based on application, the cell culture media storage containers market is divided into biopharmaceutical production, tissue engineering, diagnostic, and regenerative medicine. The biopharmaceutical production segment is expected to reach USD 3.2 billion by 2032.
- Biopharmaceutical production processes rely heavily on bioprocessing technologies, where cells are cultured and manipulated to produce therapeutic proteins and other biological products. These processes require specialized and high-quality storage containers for storage, transportation and further production maintaining their viability and quality.
- As the demand for biopharmaceuticals, including vaccines, gene therapies, and other complex biological drugs, has been steadily increasing, the biotech companies are also rapidly expanding. For instance, according to the Seed Scientific, in 2021, nearly 6,600 biotech companies are involved in research and development in the U.S. alone.
Based on end-user, the cell culture media storage containers market is segmented into pharmaceutical & biotechnology companies, CROs & CMOs, and academic & research institutes. The pharmaceutical & biotechnology companies segment accounted for USD 966.1 million in 2022.
- The highest market share can be attributed to their extensive experiments and tests, large scale production for storing bulk media and solutions, various biopharmaceutical productions, innovations, and customizations, coupled with global presence.
- Furthermore, they rely on precise cell culture techniques. The advanced therapies require specialized and controlled storage containers to maintain the viability and efficacy of the produced cells. Additionally, pharmaceutical & biotechnology companies invest in state-of-the-art storage solutions to support their biopharmaceutical production processes.
The North America cell culture media storage containers market is expected to grow at 11.2% during the analysis period.
- The largest share is owing to well-developed healthcare infrastructure and facilities, regulatory environment, innovation and technological advancements, robust manufacturing industry, and strategic alliances & partnerships.
- North America, particularly the U.S., is a hub for pharmaceutical, biotechnology, and research institutions. The region invests significantly in R&D activities, driving the demand for cell culture media storage containers. The presence of numerous universities, research centers, and biopharmaceutical companies further fuels the market progression.